Novo Nordisk NVO and Aspect Biosystems announced that they are advancing their partnership into a new phase focused on ...

It’s tried repurposing a platform from its internal-combustion cars (for the EX40 and EC40, nee XC40 Recharge and C40 ...

BMW unveiled the new iX3 at CES 2026, its first Neue Klasse production model, showcasing technologies destined for 40 future models by 2027.

The mid-size electric SUV class generates huge interest, and just like the petrol-engined XC60, the EX60 is poised to ...

Prices for the EX60 are yet to be revealed but expect it to be positioned competitively in the £50k-£65k range against the ...

Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to ...

U.S. Patent No. 12,329,781 relates to Minovia’s proprietary mitochondrial augmentation technology for the treatment of renal diseases, including renal tubulopathy, kidney insufficiency, and chronic ...

He consults at Nuffield Health Leeds and Nuffield Health York. Arrange an in-person or video consultation at mrkailasmunot.co ...

Korro Bio, Inc. ( KRRO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 1:30 PM EST ...

Coherus Oncology, Inc. ( CHRS) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 1:30 PM EST Good morning everyone. It's still the morning. Thanks for joining us for another session at ...

Detailed price information for Avant Technologies Inc (AVAI) from The Globe and Mail including charting and trades.

Minovia Therapeutics Ltd. ("Minovia" or the "Company"), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases ...